Cargando…

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches

Pancreatic ductal adenocarcinoma is a lethal disease for which radical surgery and chemotherapy represent the only curative options for a small proportion of patients. Recently, FOLFIRINOX and nab-paclitaxel plus gemcitabine have improved the survival of metastatic patients but prognosis remains poo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parente, Paola, Parcesepe, Pietro, Covelli, Claudia, Olivieri, Nunzio, Remo, Andrea, Pancione, Massimo, Latiano, Tiziana Pia, Graziano, Paolo, Maiello, Evaristo, Giordano, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312626/ https://www.ncbi.nlm.nih.gov/pubmed/30662458 http://dx.doi.org/10.1155/2018/7530619

Ejemplares similares

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept
por: Giordano, Guido, et al.
Publicado: (2014)

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
por: Giordano, Guido, et al.
Publicado: (2017)

Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer
por: Parcesepe, Pietro, et al.
Publicado: (2016)

Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study
por: Tavano, Francesca, et al.
Publicado: (2023)

Immune Resistance and EGFR Antagonists in Colorectal Cancer
por: Giordano, Guido, et al.
Publicado: (2019)

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2015)

Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma
por: Ni, Bo, et al.
Publicado: (2023)

Single-cell proteo-genomic reveals a comprehensive map of centrosome-associated spliceosome components
por: Cerulo, Luigi, et al.
Publicado: (2023)

Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial
por: Martini, Giulia, et al.
Publicado: (2023)

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)
por: Giommoni, Elisa, et al.
Publicado: (2021)

Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era
por: Giordano, Guido, et al.
Publicado: (2021)

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2019)

Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma
por: Sperb, Nadine, et al.
Publicado: (2020)

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process
por: Pancione, Massimo, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Li, Ke-Yu, et al.
Publicado: (2020)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
por: Zhang, Jingchang, et al.
Publicado: (2022)

Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
por: Smith, Caitlyn, et al.
Publicado: (2022)

Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
por: Gola, Michał, et al.
Publicado: (2022)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
por: Ciardiello, Davide, et al.
Publicado: (2021)

Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941
por: Ciardiello, Davide, et al.
Publicado: (2022)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
por: Pancione, Massimo, et al.
Publicado: (2014)

Systems biology analysis of gene expression data and gene network reverse-engineering approaches reveal NFAT5 as a candidate biomarker in Inflammatory Breast Cancer
por: Remo, Andrea, et al.
Publicado: (2015)

MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma
por: Mazza, Tommaso, et al.
Publicado: (2017)

Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression
por: Pancione, Massimo, et al.
Publicado: (2012)

Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor Microenvironment and Barriers to Treatment
por: Kane, Sujata, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
por: Gartrell, Robyn D., et al.
Publicado: (2022)

Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma
por: Lambin, Thomas, et al.
Publicado: (2022)

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Skorupan, Nebojsa, et al.
Publicado: (2022)

Translocation of Oral Microbiota into the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment
por: McKinley, Kelley N. L., et al.
Publicado: (2023)

Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
por: Tavano, Francesca, et al.
Publicado: (2018)

Characterizing the Crosstalk of NCAPG with Tumor Microenvironment and Tumor Stemness in Stomach Adenocarcinoma
por: Xiang, Zheng, et al.
Publicado: (2022)

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients
por: Tavano, Francesca, et al.
Publicado: (2014)

Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
por: Pu, Ning, et al.
Publicado: (2020)

The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
por: Herremans, Kelly M., et al.
Publicado: (2022)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma
por: Igata, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o671jdh2ciblgj3l9vqia2h1v6